11 results
8-K
EX-99.1
IMGN
Immunogen, Inc.
19 Oct 20
ImmunoGen and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize Mirvetuximab Soravtansine in Greater China
8:57am
work in ADCs into long-term relationships that create sustainable value for ImmunoGen and our partners. We look forward to working closely with Huadong
10-KT
hozcd jgr7o1
3 Mar 17
Annual report (with FYE transition)
12:00am
- Prev
- 1
- Next